Celcuity Inc. Income Statement
CELC / Health Care|9 years of annual SEC 10-K data (FY2016-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 9 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $9.1M | $5.6M | $4.1M | $2.6M | $1.9M | $1.5M | $1.6M | $972.5K | $263.7K |
| R&D Expense | $104.2M | $60.6M | $35.3M | $25.8M | $7.7M | $6.3M | $6.3M | $5.0M | $3.1M |
| Operating Income | -$113.3M | -$66.2M | -$39.4M | -$28.4M | -$9.6M | -$7.8M | -$7.9M | -$6.0M | -$3.3M |
| Interest Expense | - | $5.3M | $2.1M | $1.3M | $120 | $159 | $111 | $451.7K | $0 |
| Income Tax | - | - | - | - | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$111.8M | -$63.8M | -$40.4M | -$29.6M | -$9.5M | -$7.4M | -$7.5M | -$6.3M | -$3.3M |
| EPS (Basic) | -$2.83 | -$2.69 | -$2.64 | -$2.21 | - | - | - | - | - |
| EPS (Diluted) | -$2.83 | -$2.69 | -$2.64 | - | - | - | - | - | - |
| Shares Outstanding | 39.4M | 23.7M | 15.4M | 13.4M | 10.3M | 10.2M | 10.1M | 10.1M | 6.3M |